SCHEMBL5073532

SCHEMBL5073532

NNC(=O)c1cc(CO)cc(C(=O)NN)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.54
ALDH1A1 P00352 7/20 0.54
MAPT P10636 4/20 0.54
LMNA P02545 3/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
BLM P54132 2/20 0.54
GAA P10253 2/20 0.54
HTT P42858 2/20 0.54
NSD2 O96028 1/20 0.54
ALPL P05186 1/20 0.54
POLB P06746 1/20 0.54
ALPI P09923 1/20 0.54
ALPG P10696 1/20 0.54
APEX1 P27695 1/20 0.54
RECQL P46063 1/20 0.54
CASP6 P55212 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
MPO P05164 2/20 0.45
CYP3A4 P08684 2/20 0.45
KDM5A P29375 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893743 0.85 KDM4E (0.68) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL21638087 0.83 ALDH1A1 (0.50) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL12254094 0.79 ALDH1A1 (0.61) KDM4EALDH1A1MAPTLMNABLM
SCHEMBL31148957 0.79 KDM4E (0.56) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL1364607 0.77 MPO (0.61) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL25286067 0.76 KDM4E (0.58) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL21638084 0.76 KDM4E (0.64) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL4447450 0.76 PRSS1 (0.42) MAPTL3MBTL1BLMPOLBRECQL
SCHEMBL11341058 0.76 KDM4E (0.58) KDM4EALDH1A1MAPTLMNAL3MBTL1
SCHEMBL1975230 0.76 KDM4E (0.58) KDM4EALDH1A1MAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309730-B1 NEW HYDRAZIDE BUILDING BLOCKS AND HYDRAZIDE MODIFIED BIOMOLECULES NANOGEN RECOGNOMICS GMBH (DE) 2008-11-26 EP disclosed
US-7129229-B2 Hydrazide building blocks and hydrazide modified biomolecules NANOGEN RECOGNOMICS GMBH (DE) 2006-10-31 US disclosed
US-20040087807-A1 Macromolecules having hydrazide attachment moieties and reagents for their production SANOFI-AVENTIS S.A. (FR) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087807-A1 Macromolecules having hydrazide attachment moieties and reagents for their production DNPEP, HPSE, HLCS KDM4E 2152/4885ALDH1A1 333/4885MAPT 2150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.